Cited by 568Cancer-related Molecular PathwaysGenomics and Chromatin DynamicsChromatin Remodeling and Cancer

The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.

The expanding universe of p53 targets

Menendez, Daniel, Inga, Alberto, Resnick, Michael A.·2009·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

The p53 tumour suppressor is modified through mutation or changes in expression in most cancers, leading to the altered regulation of hundreds of genes that are directly influenced by this sequence-specific transcription factor. Central to the p53 master regulatory network are the target response element (RE) sequences. The extent of p53 transactivation and transcriptional repression is influenced by many factors, including p53 levels, cofactors and the specific RE sequences, all of which contribute to the role that p53 has in the aetiology of cancer. This Review describes the identification and functionality of REs and highlights the inclusion of non-canonical REs that expand the universe of genes and regulation mechanisms in the p53 tumour suppressor network.

Integrity signals

Registry

Crossref · 10.1038/nrc2730

Cites

208 of 208 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
WebLogo: A Sequence Logo Generator: Figure 1Preprint
Crooks, G. E., Hon, G. C., Chandonia, J., & Brenner, S. E. (2004) · Genome Research · doi:10.1101/gr.849004 · Cited by 12,480
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Live or let die: the cell's response to p53
Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,231
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921

Flagged first, then by citations

Show all 208 references

Sorted by citations

Items 401–500 of 567

Human transcription factors in yeast: the fruitful examples of P53 and NF-кB
Sharma, V., Monti, P., Fronza, G., & Inga, A. (2016) · FEMS Yeast Research · doi:10.1093/femsyr/fow083 · Cited by 10
Self-citation
The effect of trans-resveratrol on the expression of the human DNA-repair associated genes
Uchiumi, F., Arakawa, J., Takihara, Y., Akui, M., Ishibashi, S., & Tanuma, S. (2016) · Integrative Molecular Medicine · doi:10.15761/imm.1000246 · Cited by 9
Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53
Omran, M., Blomqvist, L., Brandberg, Y., Pal, N., Kogner, P., Ståhlbom, A. K., Tham, E., & Bajalica‐Lagercrantz, S. (2020) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-020-0133-5 · Cited by 8
Evaluating the Influence of a G-Quadruplex Prone Sequence on the Transactivation Potential by Wild-Type and/or Mutant P53 Family Proteins through a Yeast-Based Functional Assay
Monti, P., Brázda, V., Bohálová, N., Porubiaková, O., Menichini, P., Speciale, A., Bocciardi, R., Inga, A., & Fronza, G. (2021) · Genes · doi:10.3390/genes12020277 · Cited by 9
Self-citation
Sequence Properties of an Intramolecular Interaction that Inhibits p53 DNA Binding
Gregory, E., & Daughdrill, G. W. (2022) · Biomolecules · doi:10.3390/biom12111558 · Cited by 8
Estradiol shows anti-skin cancer activities through decreasing MDM2 expression
Li, L., Feng, J., Chen, Y., Li, S., Ou, M., Sun, W., & Tang, L. (2016) · Oncotarget · doi:10.18632/oncotarget.14275 · Cited by 8
A multi-modal proteomics strategy for characterizing posttranslational modifications of tumor suppressor p53 reveals many sites but few modified formsPreprint
DeHart, C. J., Fornelli, L., Anderson, L. C., Fellers, R. T., Lü, D., Hendrickson, C. L., Lahav, G., Gunawardena, J., & Kelleher, N. L. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/455527 · Cited by 8
In search of new prognostic molecular markers in ovarian cancer
Laatio, L. (2012) · Cited by 7
KDM7A-DT induces genotoxic stress, tumorigenesis, and progression of p53 missense mutation-associated invasive breast cancer
Giannakakis, A., Tsifintaris, M., Gouzouasis, V., Ow, G. S., Aau, M. Y., Papp, C., Ivshina, A. V., & Kuznetsov, V. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1227151 · Cited by 7
Differential Expression of Senescence and Cell Death Factors in Non-Small Cell Lung and Colorectal Tumors Showing Telomere Attrition
Fernández‐Marcelo, T., Morán, A., de Juan, C., Pascua, I. P., Head, J., Gómez, A. M., Hernándo, F., García‐Asenjo, J. A. L., Hernández, S., Sánchez-Pernaute, A., et al. (2012) · Oncology · doi:10.1159/000335678 · Cited by 7
Targeting p53 as a Promising Therapeutic Option for Cancer By Re-Activating the Wt Or Mutant p53’s Tumor Suppression
Węsierska‐Gądek, J. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0175 · Cited by 7
Wild-type p53 suppresses formin-binding protein-17 (FBP17) to reduce invasion
Suman, P., Mehta, V., Craig, A. W., & Chander, H. (2022) · Carcinogenesis · doi:10.1093/carcin/bgac015 · Cited by 7
A molecular mechanism for the “digital” response of p53 to stress
Safieh, J., Chazan, A., Saleem, H., Vyas, P., Danin‐Poleg, Y., Ron, D., & Haran, T. E. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2305713120 · Cited by 7
A Second Career for p53 as A Broad-Spectrum Antiviral?
Harford, J. B. (2023) · Viruses · doi:10.3390/v15122377 · Cited by 7
Nuclear Localization Signal and p53 Binding Site in MAP/ERK Kinase Kinase 1 (MEKK1)
Chipps, E., Protzman, A. D., Muhi, M. Z., Ando, S., Calvet, J. P., & Islam, M. R. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25238 · Cited by 7
Jetzt wird es ernst: strukturbasiertes Design von Mdm2/Mdmx‐p53‐Inhibitoren
Popowicz, G. M., Dömling, A. S. S., & Holak, T. A. (2011) · Angewandte Chemie · doi:10.1002/ange.201003863 · Cited by 7
Topoisomerases and Apoptosis
Sordet, O., & Solier, S. (2011) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-0323-4_19 · Cited by 7
TP53 Binding to BRCA1 and RAD51 in MCF7 and MDA-MB-468 Breast Cancer Cell Lines In vivo and In vitro.
Rasti, M., & Azimi, T. (2015) · Europe PMC (PubMed Central) · Cited by 7
Suppression of Cellular Proliferation in PC3 Prostate Cancer Cells by Green Tea Extract Through Induction of miR ‐34a Expression
Moalemi, S. F. S. S., Safari, F., & Ahvati, H. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70215 · Cited by 6
Structural Basis of Mutation-Dependent p53 Tetramerization Deficiency
Rigoli, M., Spagnolli, G., Lorengo, G., Monti, P., Potestio, R., Biasini, E., & Inga, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147960 · Cited by 6
Self-citation
MZF1 (Myeloid Zinc Finger 1) activates transcriptional activity of p53 and suppresses breast cancer cell proliferation via acetyltransferase PCAF (P300/CBP associated factor)
Li, B., Li, S., Shi, X., Zhang, Y., Xin, Z., Yang, Y., Zhao, B., Ren, P., & Wu, H. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.11.005 · Cited by 6
A Brief Overview of the Molecular Landscape of Myelodysplastic Neoplasms
Abdulbaki, R., & Pullarkat, S. T. (2024) · Current Oncology · doi:10.3390/curroncol31050175 · Cited by 6
The role of the p53 protein in nitrosative stress-induced apoptosis of PC12 rat pheochromocytoma cells
Varga, J., Bátor, J., Péter, M., Árvai, Z., Pap, M., Sétáló, G., & Szeberényi, J. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1932-7 · Cited by 6
Differential Salt-Induced Dissociation of the p53 Protein Complexes with Circular and Linear Plasmid DNA Substrates Suggest Involvement of a Sliding Mechanism
Šebest, P., Brázdová, M., Fojta, M., & Pivoňková, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16023163 · Cited by 6
Impact of the Adenoviral E4 Orf3 Protein on the Activity and Posttranslational Modification of p53
DeHart, C. J., Perlman, D. H., & Flint, S. J. (2015) · Journal of Virology · doi:10.1128/jvi.03072-14 · Cited by 7
Cytotoxic Efficacy and Resistance Mechanism of a TRAIL and VEGFA-Peptide Fusion Protein in Colorectal Cancer Models
Kopczyński, M., Statkiewicz, M., Cybulska, M., Kuklinska, U., Unrug-Bielawska, K., Sandowska-Markiewicz, Z., Grochowska, A., Gajewska, M. E., Kulecka, M., Ostrowski, J., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063160 · Cited by 6
Analysis of the p53/CEP-1 regulated non-coding transcriptome in C. elegans by an NSR-seq strategy
Xu, D., Wei, G., Lü, P., Luo, J., Chen, X., Skogerbø, G., & Chen, R. (2014) · Protein & Cell · doi:10.1007/s13238-014-0071-y · Cited by 6
Integrated analysis of miRNA and mRNA expression profiles in p53-edited PFF cells
Qiao, C., Liu, W., Jiang, H., He, M., Yang, Q., & Xing, Y. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1742852 · Cited by 6
19q13.12 KRAB zinc-finger protein ZNF383 represses p53 signaling pathway by interacting with p53
Liang, Y., Zhang, X., Geng, W., Wang, Y., Ding, Y., Song, Q., Yuan, Y., Zhao, C., Tian, Z., Wang, J., et al. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110405 · Cited by 5
Transactivation by partial function P53 family mutants is increased by the presence of G-quadruplexes at a promoter site
Vojsovič, M., Kratochvilová, L., Bohálová, N., Šislerová, L., Rashed, Z. E., Menichini, P., Inga, A., Monti, P., & Brázda, V. (2023) · Biochimie · doi:10.1016/j.biochi.2023.09.026 · Cited by 7
Self-citation
Characterization of chicken p53 transcriptional function via parallel genome-wide chromatin occupancy and gene expression analysis
Chen, Z., Cui, L., Xu, L. M., Liu, Z., Liang, Y., Li, X., Zhang, Y., Li, Y., Liu, S., & Li, H. (2022) · Poultry Science · doi:10.1016/j.psj.2022.102164 · Cited by 5
Potential of siRNA-Bearing Subtilosomes in the Treatment of Diethylnitrosamine-Induced Hepatocellular Carcinoma
Jamal, F., Ahmed, G., Farazuddin, M., Altaf, I., Farheen, S., Zia, Q., Azhar, A., Ahmad, H., Khan, A. A., Somavarapu, S., et al. (2023) · Molecules · doi:10.3390/molecules28052191 · Cited by 5
PER2 expression and cellular localization play a critical role in tumor aggressiveness and drug resistance in an in vitro model of hepatocellular carcinoma
Negri, M., Amatrudo, F., Provvisiero, D. P., Patalano, R., Trinchese, G., Cimmino, F., de Angelis, C., Simeoli, C., Auriemma, R. S., Mollica, M. P., et al. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2024.193 · Cited by 5
A/T gap tolerance in the core sequence and flanking sequence requirements of non-canonical p53 response elements
Cai, B., Chao, C., Lin, H.-C., Huang, H., Kannagi, R., & Chen, J.-Y. (2016) · The Journal of Biochemistry · doi:10.1093/jb/mvw005 · Cited by 5
Interfacial properties of p53-DNA complexes containing various recognition elements
Černocká, H., Fojt, L., Adámik, M., Brázdová, M., Paleček, E., & Ostatná, V. (2019) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2019.113300 · Cited by 5
Association of intron and exon polymorphisms of p53 gene in Iranian patients with gastritis.
Sadeghi, R. N., Sahba, N., Vahedi, M., Mohebbi, S. R., & Zali, M. R. (2013) · Gastroenterology and hepatology from bed to bench. · Cited by 5
A small kiss of death for cancer
Eggert, A., & Schulte, J. H. (2010) · Nature Medicine · doi:10.1038/nm1010-1079 · Cited by 5
TP53 inhibitor PFTα increases the sensitivity of arsenic trioxide in TP53 wildtype tumor cells
Wang, H., Wang, X., Xu, L., & Zhang, J. (2022) · FEBS Open Bio · doi:10.1002/2211-5463.13366 · Cited by 4
Dynamic In Vivo Mapping of the Methylproteome Using a Chemoenzymatic Approach
Farhi, J., Emenike, B., Lee, R. S., Sad, K., Fawwal, D. V., Beusch, C. M., Jones, R. B., Verma, A. K., Jones, C. Y., Foroozani, M., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c08175 · Cited by 6
Downregulation of DDIT4 levels with borneol attenuates hepatotoxicity induced by gilteritinib
Yin, Y., Cao, Y., Zhou, Y., Xu, Z., Luo, P., Yang, B., He, Q., Yan, H., & Yang, X. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116869 · Cited by 4
Partial p53-dependence of anisomycin-induced apoptosis in PC12 cells
Schipp, R., Varga, J., Bátor, J., Vecsernyés, M., Árvai, Z., Pap, M., & Szeberényi, J. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3035-8 · Cited by 4
Hereditary Breast Cancer Syndromes: Molecular Pathogenesis and Diagnostics
Vos, S., van Diest, P. J., van der Wall, E., & van Diest, P. J. (2015) · Wiley eBooks · doi:10.1002/9780470015902.a0005375 · Cited by 4
Manumycin Polyketides Act as Molecular Glues Between UBR7 and P53 to Impair Breast Cancer PathogenicityPreprint
Isobe, Y., Okumura, M., White, R., McGregor, L. M., McKenna, J. M., Tallarico, J. A., Schirle, M., Maimone, T. J., & Nomura, D. K. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/814285 · Cited by 4
Simplify p53: just an activator
Engeland, K. (2015) · Oncotarget · doi:10.18632/oncotarget.3032 · Cited by 3
Identification and characterization of Bombyx mori homologs of Bonus, Mdm2, Rad6, Sce, and Synoviolin
Millado, J. B. H., Hamajima, R., Sugiura, W., Makino, S., Kobayashi, M., & Ikeda, M. (2021) · Journal of insect biotechnology and sericology · doi:10.11416/jibs.90.2_021 · Cited by 3
p53 oligomerization status as an indicator of sensitivity of p53-wildtype neuroblastomas to the combination of DNA damaging agent and Chk1 inhibitor
Levesque, A. A., Pappalardo, R. M., Puli, P., Enzor, L. A., & Angeles, C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263463 · Cited by 3
CK1α deficiency impairs mouse uterine adenogenesis by inducing epithelial cell apoptosis through GSK3β pathway and inhibiting Foxa2 expression through p53 pathway
Zhang, D., Lu, C., Zhou, Y., Luo, X., Guo, H., Zhang, J., Gao, Q., Liu, H., Shang, C., & Cui, S. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad144 · Cited by 3
The presence of a G-quadruplex prone sequence upstream of a minimal promoter increases transcriptional activity in the yeast Saccharomyces cerevisiae
Kratochvilová, L., Vojsovič, M., Valková, N., Šislerová, L., Rashed, Z. E., Inga, A., Monti, P., & Brázda, V. (2023) · Bioscience Reports · doi:10.1042/bsr20231348 · Cited by 7
Self-citation
Microarray and ChIP-seq data analysis revealed changes in p53-mediated transcriptional regulation in Nutlin-3-treated U2OS cells
Zhao, S., NIU, F., Xu, C., Ye, L., Bi, G.-B., Chen, L., Gong, P., TIAN, G., & Nie, T.-H. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3933 · Cited by 3
Targeting the Ataxia Telangiectasia and Rad3 Signaling Pathway to Overcome Chemoresistance in Cancer
Kwok, M., & Stanković, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813753-6.00010-x · Cited by 3
Sequence Variation in the Response Element Determines Binding by the Transcription Factor p73
Ramos, A., Tse, P. W., Wang, J. J. J., Ethayathulla, A. S., & Viadiu, H. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00152 · Cited by 3
Structure–activity relationship study of 4-substituted piperidines at Leu26 moiety of novel p53–hDM2 inhibitors
Tian, Y., Ma, Y., Gibeau, C. R., Lahue, B. R., Shipps, G. W., Strickland, C., & Bogen, S. L. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.03.078 · Cited by 3
Selenium and Senescence
Wu, R. T. Y., & Cheng, W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-418680-4.00021-x · Cited by 4
WRAP53 Unwrapped; Roles in Nuclear Architecture and Cancer
Mahmoudi, S. (2011) · Figshare · Cited by 3
p53 Isoforms as Modifiers of the p53-Dependent Responses: A Hidden Code?
Bartolomei, L., Pretto, B., Brugnara, S., Sontacchi, A., Dassi, V., Bousrih, A., Damaggio, C., Flangini, F., Bisio, A., & Ciribilli, Y. (2026) · Cancers · doi:10.3390/cancers18071057 · Cited by 3
Cell Cycle, DNA Replication, Centrosomes, Centrioles and Cell Division
Mierke, C. T. (2020) · Biological and medical physics, biomedical engineering · doi:10.1007/978-3-030-58532-7_15 · Cited by 2
Somatic Mutations in TP53 Gene in Colombian Patients With Non-melanoma Skin Cancer
Gutiérrez-Castañeda, L. D., Nova, J. A., & Cerezo-Cortés, M. I. (2022) · Cancer Diagnosis & Prognosis · doi:10.21873/cdp.10084 · Cited by 2
The Functionality of p53 in Thyroid Cancer
Ray, D., Matthew, T., & Gal, S. (2012) · InTech eBooks · doi:10.5772/25554 · Cited by 2
New Insights into P53 Signalling and Cancer: Implications for Cancer Therapy
Nigro, C. L. (2014) · Journal of Tumor · Cited by 2
Effect of intense THz pulses on expression of genes associated with skin cancer and inflammatory skin conditions
Titova, L. V., Ayesheshim, A. K., Purschke, D. N., Golubov, A., Rodriguez‐Juarez, R., Wóycicki, R. K., Hegmann, F. A., & Kovalchuk, O. (2014) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2044167 · Cited by 2
Cluster Analysis of p53 Binding Site Sequences Reveals Subsets with Different Functions
Lim, J., Latysheva, N. S., Iggo, R. D., & Barker, D. (2016) · Cancer Informatics · doi:10.4137/cin.s39968 · Cited by 2
Tissue-Specific Functions of p53 During Kidney Development
Saifudeen, Z. R. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-51436-9_5 · Cited by 2
Some Aspects of Carcinogenesis Associated with Genetic and Epigenetic Factors
Vf, M., Шуленина, Л. В., Vasilyeva, I. M., Салеева, Д. В., & Засухина, Г. Д. (2019) · Biology Bulletin Reviews · doi:10.1134/s2079086419020075 · Cited by 2
Biochemical characterization of ratfish (Chimaera monstrosa) liver oil; cytotoxic and antineoplastic evaluation in cancer cell lines
Mallakin, A., Taneja, P., Inoue, K., Ward, N. A., & Dahms‬, H.-U. (2018) · Integrative Clinical Medicine · doi:10.15761/icm.1000137 · Cited by 2
Treatment and Prognostic Implications of Strong PD-L1 Expression in Primary Hepatic Sarcomatoid Carcinoma
Radhakrishnan, S., Martin, C. A., Vij, M., Subbiah, K., Raju, L. P., Gowrishankar, G., Veldore, V. H., Kaliamoorthy, I., Rammohan, A., & Rela, M. (2024) · Immunotherapy · doi:10.2217/imt-2023-0243 · Cited by 2
Systematic Characterization of p53-Regulated Long Noncoding RNAs across Human Cancers Reveals Remarkable Heterogeneity among Different Tumor Types
Regunath, K., Fomin, V., Liu, Z., Wang, P., Hoque, M., Tian, B., Rabadán, R., & Prives, C. L. (2024) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-0295 · Cited by 2
Coordinated interaction of multifunctional members of the p53 family determines many key processes in multicellular organisms
Vilgelm, A. E., Zaika, A. I., & Prassolov, V. (2011) · Molecular Biology · doi:10.1134/s002689331101016x · Cited by 2
Identifying a TFIID interactome via integrated biochemical and high-throughput proteomic studiesPreprint
Liu, W., Song, L., Dailey, G. M., Piasecka, A., & Coleman, R. A. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/111682 · Cited by 2
DNA Sequence-Dependent Binding of Linker Histone gH1 Regulates Nucleosome Conformations
Zhang, H., Huo, Q. Y., & Gao, Y. Q. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c03785 · Cited by 1
Dual role of proliferating cell nuclear antigen monoubiquitination in facilitating Fanconi anemia-mediated interstrand crosslink repair
Shah, R., Aslam, M. A., Spanjaard, A., de Groot, D., Zürcher, L. M., Altelaar, M. A. F., Hoekman, L., Pritchard, C. E. J., Pilzecker, B., van den Berk, P. C. M., et al. (2024) · PNAS Nexus · doi:10.1093/pnasnexus/pgae242 · Cited by 1
Metabolic profiling of the TME uncovers the contrasting impacts of CKMT2 and PDE2A in CRC progression and therapeutic response
Fu, Y., Lai, J., Huang, K., Liu, L., & Liao, G. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1732137 · Cited by 1
GC-MS guided phytochemical profiling of Bauhinia tomentosa flowers: molecular docking against HPV-E6 and p53 in cervical cancer
Trisha, S., & Balaji, R. (2026) · Scientific Reports · doi:10.1038/s41598-026-40361-5 · Cited by 1
Hypertranscription caused by p53 deficiency triggers nucleotide insufficiency that induces replication stress and genomic instability
Zaatra, W., Philippos, G., Smirnov, P., Milo, S., Otoničar, J., Chan, M., Harel, M., Devens, F., Goldberg, T., Eliassaf, A., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.08.003 · Cited by 2
The new function of p53 family and its pathway related pro-teins in female reproduction
Zhu, H., Li, A., Yu, J., Xiang, C.-J., Su, S.-D., Huang, L., Fang, Y., Luo, Y., & Tang, W. (2012) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2012.00943 · Cited by 1
The Future of Carcinogenicity Testing
Pandiri, A. R., Kovi, R. C., Alden, C. L., & Sills, R. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12386-8 · Cited by 1
Co nás učí nádory. Paralely v chování buněk a lidí
Šmardová, J. (2021) · Masarykova univerzita eBooks · doi:10.5817/cz.muni.m210-9700-2021 · Cited by 1
Operation p53 Hunt to combat cancer Theaflavins in action
Das, T. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s270 · Cited by 1
Defektif Homolog Rekombinasyon DNA Tamiri ve PARP İnhibisyonu Arasındaki Sentetik Letal Etkileşim
Toy, Y., Gündoğdu, R., SEVER, A., & Erdoğan, M. K. (2022) · Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi · doi:10.21597/jist.1095366 · Cited by 1
A new era of studying p53-mediated transcription activation
Liu, W.-L., Coleman, R. A., & Singh, S. K. (2017) · Transcription · doi:10.1080/21541264.2017.1345354 · Cited by 1
Transcription Factors as Detection and Diagnostic Biomarkers in Cancer
Goh, W. L., Assah, E., Zheng, X. T., Lane, D. P., Ghadessy, F. J., & Tan, Y. N. (2017) · Springer eBooks · doi:10.1007/978-981-10-4726-8_2 · Cited by 1
Ipr1 Regulation by Cyclic GMP-AMP Synthase/Interferon Regulatory Factor 3 and Modulation of Irgm1 Expression via p53
Liu, F., Xue, H., Ke, J., Wu, Y., Yao, K., Liang, S., Xu, A., & Zhang, Y. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00471-19 · Cited by 1
Why typos in DNA may help to fuel atherogenesis and inflammation prior to heart attacks, ischemic heart disease, and sudden-death ischemic heart disease: roles of unrecognized ionized hypomagnesemia and epigenetics
Altura, B. M., Shah, N. C., Shah, G. J., & Altura, B. T. (2020) · International Journal of Molecular Biology Open Access · doi:10.15406/ijmboa.2020.05.00137 · Cited by 1
Vulnerabilidades específicas de células malignas humanas dependentes de Ras oncogênico: FGF2 e PMA como supressores de tumor
Zeidler, J. D. (2012) · doi:10.11606/t.46.2012.tde-23042013-105402 · Cited by 1
Dynamics of p53 DNA binding sites contributes to functional selectivity of p53-driven gene expressionPreprint
Safieh, J., Chazan, A., Vyas, P., Saleem, H., Danin‐Poleg, Y., Ron, D., & Haran, T. E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.18.460898 · Cited by 1
Correction: GW8510 Increases Insulin Expression in Pancreatic Alpha Cells through Activation of p53 Transcriptional Activity
Fomina‐Yadlin, D., Kubicek, S., Vetere, A., He, K. H. H., Schreiber, S. L., & Wagner, B. K. (2012) · PLoS ONE · doi:10.1371/annotation/c41ac082-32ac-4837-b4ed-9fd8ad91c1e0 · Cited by 1
p53
Botcheva, K., & Anderson, C. W. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0461-4_57 · Cited by 1
TP53 mutation–associated and copy number–dependent KDM7A-DT expression affects DNA repair and promotes invasive breast cancer progressionPreprint
Giannakakis, A., Tsifintaris, M., Triantafyllou, C., Gouzouasis, V., Ow, G. S., Aau, M. Y., Papp, C., Ivshina, A. V., & Kuznetsov, V. A. (2022) · Research Square · doi:10.21203/rs.3.rs-1896103/v2 · Cited by 1
P53 deficiency triggers hypertranscription, inducing nucleotide insufficiency causing replication stress, and genomic instabilityPreprint
Zaatra, W., Philippos, G., Smirnov, P., Milo, S., Otoničar, J., Chan, M., Harel, M., Devens, F., Goldberg, T., Eliassaf, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.17.649416 · Cited by 1
Etude in vivo du rôle de la région régulatrice en 3’ du locus de chaîne lourde d’immunoglobuline dans la dérégulation d’oncogènes et l’émergence de lymphomes
Fiancette, R. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
Molecular Features and Clinical Implications in Gastric Cancer
Yves, & Settmacher, U. (2011) · InTech eBooks · doi:10.5772/20830
Wig-1: A p53 target that regulates the mRNA of p53 and Myc - and more?
Vilborg, A. (2010) · Figshare
NEW TARGET GENES FOR TUMOR SUPPRESSORS p53 AND p73 IN REGENERATING LIVER
Kurinna, S. M. (2010) · Digital Commons-TMC (Texas Medical Center)
A computational approach to discovering p53 binding sites in the human genome
Lim, J. (2013) · St Andrews Research Repository (St Andrews Research Repository)
TP53 mutations in myelodysplastic syndromes with deletion of 5q
Saft, L. (2013) · Figshare
Mechanisms of p53-mediated intrinsic and extrinsic tumor suppression
Li, H. (2014) · Figshare
The Tumor’s Normativity: Normative Structures, Action Norms and Decision Maxims as Therapeutic Targets for Tumor Therapy
Reichle, A., & Hahn, J. (2013) · Springer eBooks · doi:10.1007/978-94-007-6866-6_10
Epigenetic Modulation of Cell Cycle: An Overview
Montanari, M., Giordano, A., Cintorino, M., & Macaluso, M. (2011) · Wiley eBooks · doi:10.1002/9781118005743.ch1
Marqueurs moléculaires prédictifs de réponse aux thérapies ciblées dans les cancers digestifs
Perkins, G. (2012) · theses.fr (ABES) · doi:10.70675/5b4631efzc0e5z4dddz8408z43ab410793f3
Modulation of p53's transcriptional function by small molecules
Nikulenkov, F. (2011) · Figshare
The Facilitation of Protein-DNA Search and Recognition by Multiple Modes of Binding
Leith, J. S. (2012) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)

Authors: Menendez, D., Inga, A., & Resnick, M. A.
Affiliations: National Institutes of Health (US)
Corresponding author: Resnick, Michael A.
ORCID: Inga, Alberto
Resnick, Michael A.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2009-10
Volume: 9
Issue: 10
Pages: 724-737
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc2730
OpenAlex: W2094375196
Cited by: 568
References: 208
Citations by year: 2026: 11 · 2025: 8 · 2024: 11 · 2023: 17 · 2022: 28 · 2021: 18 · 2020: 23 · 2019: 28 · 2018: 31 · 2017: 42 · 2016: 44 · 2015: 44 · 2014: 54 · 2013: 59 · 2012: 56
FWCI: 4.10
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute of Environmental Health Sciences (Z01ES065079)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: p53, transcriptional regulation, tumour suppressor, p53 target genes, p53 transactivation, transcriptional repression, cancer etiology
MeSH terms: Humans, Mutation, Neoplasms, Gene Expression, Genes, p53, Tumor Suppressor Protein p53, Response Elements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The expanding universe of p53 targets

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks